Celgene Corp (NASDAQ: CELG)DRUGS - Biotechnology
Sector: Health Care
Stock price data as of 09/20/2019
Closing price: 99.37
|Support price level:||$94.94|
|Resistance price level:||N/A|
|Relative strength index (14-day RSI)||82.5|
- CELG is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.
- Volatility is forecast to rise over the next month.
- With RSI > 70, CELG is overbought. Odds slightly favor a short-term price reversal.
- Price broke above prior resistance level - a short-term bullish signal.
|Low||High||Price as % of Range|
|200 day||50 day||20 day||10 day|
|Last month||Current estimate||Next month forecast|
- 5.7% in the next week.
- 15.4% in the next month.
- 59.9% in the next year.